Pharmaceutical Glass Packaging Market
Pharmaceutical Glass Packaging Market Forecasts to 2034 – Global Analysis By Product Type (Vials, Ampoules, Cartridges, Syringes, Bottles, Tubular Glass Containers, and Other Glass Containers), Glass Type, Packaging Format, Drug Type, Capacity, End User and By Geography
"According to Stratistics MRC, the Global Pharmaceutical Glass Packaging Market is accounted for $22.8 billion in 2026 and is expected to reach $37.9 billion by 2034, growing at a CAGR of 6.6% during the forecast period. Pharmaceutical Glass Packaging refers to the comprehensive range of glass containers and packaging solutions designed to protect, preserve, and deliver pharmaceutical products including injectable drugs, vaccines, biologics, and liquid medicines. These solutions encompass vials, ampoules, cartridges, syringes, bottles, and tubular glass containers manufactured from various glass types including Type I borosilicate glass, Type II treated soda-lime glass, Type III soda-lime glass, amber glass, and clear flint glass for primary and secondary packaging applications. This technology helps pharmaceutical companies ensure drug stability, safety, and efficacy while meeting regulatory requirements for container closure systems.
Market Dynamics:
Driver:
Growing demand for biologics and injectable drugs
The increasing demand for biologics, biosimilars, and injectable drugs serves as a primary driver for the Pharmaceutical Glass Packaging market. Biologics and injectable formulations require specialized glass packaging that provides superior chemical durability, thermal stability, and barrier properties to protect sensitive drug products. The rising prevalence of chronic diseases and the growing pipeline of biologic drugs drive demand for high-quality glass packaging. As biologics represent a growing share of pharmaceutical development, the need for reliable glass packaging continues to expand significantly.
Restraint:
High manufacturing costs and supply chain complexities
The significant manufacturing costs and supply chain complexities pose restraints to the Pharmaceutical Glass Packaging market. Producing high-quality pharmaceutical glass requires substantial investment in specialized manufacturing equipment, quality control systems, and regulatory compliance. Supply chain disruptions affecting raw materials including silica sand and energy inputs impact production costs and availability. The complexity of meeting stringent regulatory requirements for container closure systems adds to operational costs. These cost and supply constraints can limit market growth.
Opportunity:
Development of advanced glass coatings and delamination prevention
The development of advanced glass coatings and delamination prevention technologies presents significant opportunities for the Pharmaceutical Glass Packaging market. Innovative coatings improve drug compatibility, reduce protein adsorption, and prevent glass delamination that can compromise drug quality. Surface treatment technologies enhance the chemical durability of glass containers for sensitive biologics. As drug formulations become more complex and sensitive, the demand for advanced glass packaging solutions continues to grow, creating opportunities for manufacturers offering innovative coating technologies.
Threat:
Competition from polymer and plastic packaging alternatives
Competition from polymer and plastic packaging alternatives poses significant threats to the Pharmaceutical Glass Packaging market. Plastic containers offer advantages including reduced breakage, lighter weight, and lower cost for certain applications. Advances in polymer materials have improved compatibility with drug products. The availability of alternatives can pressure glass packaging adoption in applications where chemical compatibility and barrier requirements are less demanding. This competitive dynamic can limit growth in certain segments.
Covid-19 Impact:
The COVID-19 pandemic significantly impacted the Pharmaceutical Glass Packaging market through increased demand for vaccine packaging and supply chain disruptions. The urgent need for vaccine vials and syringes created unprecedented demand for pharmaceutical glass packaging. Manufacturers expanded production capacity to meet global vaccine packaging requirements. Supply chain challenges including raw material availability and logistics affected production. The pandemic highlighted the critical importance of reliable pharmaceutical packaging supply chains and the essential role of glass packaging in global health.
The vials segment is expected to be the largest during the forecast period
The vials segment is expected to account for the largest market share during the forecast period, driven by the widespread use of glass vials for parenteral drugs, vaccines, and biologics requiring sterile containment. Vials provide superior chemical stability, thermal resistance, and barrier properties essential for sensitive drug products. The growing demand for injectable drugs and vaccines supports continued dominance. As the pharmaceutical industry expands biologic and vaccine development, vials remain the primary packaging choice for parenteral products.
The Type I glass segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Type I glass segment is predicted to witness the highest growth rate, due to the superior chemical durability and thermal stability of borosilicate glass for sensitive biologics and injectable drugs. Type I glass provides excellent resistance to chemical attack and delamination, making it essential for pH-sensitive and high-value drug products. The growing pipeline of biologic drugs and complex formulations drives demand. As pharmaceutical development increasingly focuses on sensitive biologics, Type I glass continues to gain market share.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial investment in pharmaceutical R&D, the presence of major pharmaceutical companies, and strong regulatory requirements for drug packaging. The region's focus on drug safety and quality creates demand for high-quality glass packaging. Significant pharmaceutical spending and the emphasis on biologics development contribute to market leadership. Additionally, robust regulatory frameworks supporting container closure system integrity further fuel adoption in North America.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapid growth of the pharmaceutical industry, expanding biologics manufacturing, and increasing healthcare spending across major economies. Countries such as China, India, and South Korea are witnessing significant growth in pharmaceutical production and packaging demand. Government initiatives promoting domestic pharmaceutical manufacturing and the rise of contract development and manufacturing organizations further contribute to regional market expansion.
Key players in the market
Some of the key players in the Pharmaceutical Glass Packaging Market include SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Stevanato Group S.p.A., SGD Pharma, Corning Incorporated, Nipro Corporation, Bormioli Pharma S.p.A., Shandong Pharmaceutical Glass Co. Ltd., Stölzle Glass Group, West Pharmaceutical Services Inc., Ardagh Group S.A., DWK Life Sciences GmbH, Beatson Clark Ltd., Şişecam Group, and Owens-Illinois Inc.
Key Developments:
In June 2026, SCHOTT Pharma announced a major expansion of its pharmaceutical glass packaging production capacity to meet growing demand for vaccine vials and biologics packaging. The expansion includes new glass conversion capabilities and enhanced quality control systems.
In May 2026, Gerresheimer introduced a new line of high-performance glass syringes featuring advanced surface treatment for reduced protein adsorption and improved drug compatibility.
Product Types Covered:
• Vials
• Ampoules
• Cartridges
• Syringes
• Bottles
• Tubular Glass Containers
• Other Glass Containers
Glass Types Covered:
• Type I (Borosilicate Glass)
• Type II (Treated Soda-Lime Glass)
• Type III (Soda-Lime Glass)
• Amber Glass
• Clear (Flint) Glass
Packaging Formats Covered:
• Primary Packaging
• Secondary Packaging
Drug Types Covered:
• Injectable Drugs
• Vaccines
• Biologics & Biosimilars
• Small Molecule Drugs
• Oral Liquid Medicines
• Ophthalmic Drugs
Capacities Covered:
• Less than 10 mL
• 10–50 mL
• 51–100 mL
• Above 100 mL
End Users Covered:
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs)
• Contract Packaging Organizations (CPOs)
• Research & Academic Institutes
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
o Africa
South Africa
Egypt
Morocco
Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
"1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Pharmaceutical Glass Packaging Market, By Product Type
5.1 Vials
5.2 Ampoules
5.3 Cartridges
5.4 Syringes
5.5 Bottles
5.6 Tubular Glass Containers
5.7 Other Glass Containers
6 Global Pharmaceutical Glass Packaging Market, By Glass Type
6.1 Type I (Borosilicate Glass)
6.2 Type II (Treated Soda-Lime Glass)
6.3 Type III (Soda-Lime Glass)
6.4 Amber Glass
6.5 Clear (Flint) Glass
7 Global Pharmaceutical Glass Packaging Market, By Packaging Format
7.1 Primary Packaging
7.2 Secondary Packaging
8 Global Pharmaceutical Glass Packaging Market, By Drug Type
8.1 Injectable Drugs
8.2 Vaccines
8.3 Biologics & Biosimilars
8.4 Small Molecule Drugs
8.5 Oral Liquid Medicines
8.6 Ophthalmic Drugs
9 Global Pharmaceutical Glass Packaging Market, By Capacity
9.1 Less than 10 mL
9.2 10–50 mL
9.3 51–100 mL
9.4 Above 100 mL
10 Global Pharmaceutical Glass Packaging Market, By End User
10.1 Pharmaceutical Companies
10.2 Biotechnology Companies
10.3 Contract Development & Manufacturing Organizations (CDMOs)
10.4 Contract Packaging Organizations (CPOs)
10.5 Research & Academic Institutes
11 Global Pharmaceutical Glass Packaging Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa
12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment
13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives
14 Company Profiles
14.1 SCHOTT Pharma AG & Co. KGaA
14.2 Gerresheimer AG
14.3 Stevanato Group S.p.A.
14.4 SGD Pharma
14.5 Corning Incorporated
14.6 Nipro Corporation
14.7 Bormioli Pharma S.p.A.
14.8 Shandong Pharmaceutical Glass Co., Ltd.
14.9 Stölzle Glass Group
14.10 West Pharmaceutical Services, Inc.
14.11 Ardagh Group S.A.
14.12 DWK Life Sciences GmbH
14.13 Beatson Clark Ltd.
14.14 Şişecam Group
14.15 Owens-Illinois, Inc.
List of Tables
1 Global Pharmaceutical Glass Packaging Market Outlook, By Region (2023-2034) ($MN)
2 Global Pharmaceutical Glass Packaging Market Outlook, By Product Type (2023-2034) ($MN)
3 Global Pharmaceutical Glass Packaging Market Outlook, By Vials (2023-2034) ($MN)
4 Global Pharmaceutical Glass Packaging Market Outlook, By Ampoules (2023-2034) ($MN)
5 Global Pharmaceutical Glass Packaging Market Outlook, By Cartridges (2023-2034) ($MN)
6 Global Pharmaceutical Glass Packaging Market Outlook, By Syringes (2023-2034) ($MN)
7 Global Pharmaceutical Glass Packaging Market Outlook, By Bottles (2023-2034) ($MN)
8 Global Pharmaceutical Glass Packaging Market Outlook, By Tubular Glass Containers (2023-2034) ($MN)
9 Global Pharmaceutical Glass Packaging Market Outlook, By Other Glass Containers (2023-2034) ($MN)
10 Global Pharmaceutical Glass Packaging Market Outlook, By Glass Type (2023-2034) ($MN)
11 Global Pharmaceutical Glass Packaging Market Outlook, By Type I (Borosilicate Glass) (2023-2034) ($MN)
12 Global Pharmaceutical Glass Packaging Market Outlook, By Type II (Treated Soda-Lime Glass) (2023-2034) ($MN)
13 Global Pharmaceutical Glass Packaging Market Outlook, By Type III (Soda-Lime Glass) (2023-2034) ($MN)
14 Global Pharmaceutical Glass Packaging Market Outlook, By Amber Glass (2023-2034) ($MN)
15 Global Pharmaceutical Glass Packaging Market Outlook, By Clear (Flint) Glass (2023-2034) ($MN)
16 Global Pharmaceutical Glass Packaging Market Outlook, By Packaging Format (2023-2034) ($MN)
17 Global Pharmaceutical Glass Packaging Market Outlook, By Primary Packaging (2023-2034) ($MN)
18 Global Pharmaceutical Glass Packaging Market Outlook, By Secondary Packaging (2023-2034) ($MN)
19 Global Pharmaceutical Glass Packaging Market Outlook, By Drug Type (2023-2034) ($MN)
20 Global Pharmaceutical Glass Packaging Market Outlook, By Injectable Drugs (2023-2034) ($MN)
21 Global Pharmaceutical Glass Packaging Market Outlook, By Vaccines (2023-2034) ($MN)
22 Global Pharmaceutical Glass Packaging Market Outlook, By Biologics & Biosimilars (2023-2034) ($MN)
23 Global Pharmaceutical Glass Packaging Market Outlook, By Small Molecule Drugs (2023-2034) ($MN)
24 Global Pharmaceutical Glass Packaging Market Outlook, By Oral Liquid Medicines (2023-2034) ($MN)
25 Global Pharmaceutical Glass Packaging Market Outlook, By Ophthalmic Drugs (2023-2034) ($MN)
26 Global Pharmaceutical Glass Packaging Market Outlook, By Capacity (2023-2034) ($MN)
27 Global Pharmaceutical Glass Packaging Market Outlook, By Less than 10 mL (2023-2034) ($MN)
28 Global Pharmaceutical Glass Packaging Market Outlook, By 10–50 mL (2023-2034) ($MN)
29 Global Pharmaceutical Glass Packaging Market Outlook, By 51–100 mL (2023-2034) ($MN)
30 Global Pharmaceutical Glass Packaging Market Outlook, By Above 100 mL (2023-2034) ($MN)
31 Global Pharmaceutical Glass Packaging Market Outlook, By End User (2023-2034) ($MN)
32 Global Pharmaceutical Glass Packaging Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
33 Global Pharmaceutical Glass Packaging Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
34 Global Pharmaceutical Glass Packaging Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs) (2023-2034) ($MN)
35 Global Pharmaceutical Glass Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)
36 Global Pharmaceutical Glass Packaging Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
